Virus-Based therapy targets Tough-to-Treat liver tumors
NCT ID NCT06283134
Summary
This early-stage study is testing a new three-part treatment for people whose colorectal cancer has spread to the liver and other treatments have stopped working. The treatment combines a specially engineered virus designed to attack cancer cells with an immunotherapy drug and a targeted cancer drug. The main goals are to find the safest dose and see if this combination can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.